Q2 EPS Estimates for Acadia Healthcare Decreased by KeyCorp

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Analysts at KeyCorp decreased their Q2 2025 earnings estimates for Acadia Healthcare in a research note issued to investors on Monday, January 6th. KeyCorp analyst M. Gillmor now forecasts that the company will earn $0.85 per share for the quarter, down from their previous estimate of $1.00. KeyCorp has a “Overweight” rating and a $70.00 price objective on the stock. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. KeyCorp also issued estimates for Acadia Healthcare’s Q3 2025 earnings at $0.92 EPS.

Other research analysts also recently issued research reports about the stock. Barclays decreased their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. TD Cowen dropped their target price on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price target for the company from $45.00 to $75.00 in a research note on Thursday, December 12th. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday. Finally, Cantor Fitzgerald reiterated a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday, December 10th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Acadia Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $70.22.

Acadia Healthcare Trading Down 0.0 %

NASDAQ:ACHC opened at $45.12 on Wednesday. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a twelve month low of $36.50 and a twelve month high of $87.77. The company has a market cap of $4.19 billion, a P/E ratio of 14.79, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The business has a 50 day moving average price of $40.43 and a two-hundred day moving average price of $58.28.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. The business had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm’s revenue was up 8.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.91 EPS.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. GAMMA Investing LLC raised its position in shares of Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after buying an additional 241 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in Acadia Healthcare during the second quarter worth about $59,000. Covestor Ltd grew its stake in Acadia Healthcare by 834.4% during the third quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after buying an additional 1,018 shares in the last quarter. DekaBank Deutsche Girozentrale acquired a new position in shares of Acadia Healthcare in the 3rd quarter valued at approximately $86,000. Finally, Assetmark Inc. increased its stake in Acadia Healthcare by 66.1% in the third quarter. Assetmark Inc. now owns 1,485 shares of the company’s stock valued at $94,000 after acquiring an additional 591 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.